GE HealthCare Technologies (NASDAQ:GEHC) Price Target Raised to $80.00

GE HealthCare Technologies (NASDAQ:GEHC) had its target price upped by JPMorgan Chase & Co. from $70.00 to $80.00 in a report issued on Thursday morning,Benzinga reports. They currently have a neutral rating on the stock.

Other equities research analysts also recently issued research reports about the company. Wells Fargo & Company boosted their target price on GE HealthCare Technologies from $75.00 to $85.00 and gave the stock an “overweight” rating in a research report on Thursday, July 30th. UBS Group raised their price objective on GE HealthCare Technologies from $67.00 to $73.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Zacks Research upgraded shares of GE HealthCare Technologies from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 11th. Barclays boosted their target price on GE HealthCare Technologies from $85.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday. Finally, Hovde Group started coverage on shares of GE HealthCare Technologies in a research note on Friday, July 17th. They set a “market perform” rating and a $14.00 price objective for the company. Twelve analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $80.57.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock opened at $76.57 on Thursday. The firm has a market cap of $34.62 billion, a P/E ratio of 16.15, a price-to-earnings-growth ratio of 1.99 and a beta of 0.73. The firm’s 50-day simple moving average is $68.45 and its 200-day simple moving average is $70.06. GE HealthCare Technologies has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.30.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 28th. The company reported $1.34 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.14. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. The business had revenue of $5.51 billion for the quarter, compared to analyst estimates of $5.35 billion. During the same quarter in the prior year, the firm earned $1.07 EPS. The firm’s quarterly revenue was up 7.2% compared to the same quarter last year. As a group, research analysts expect that GE HealthCare Technologies will post 5.02 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be issued a $0.04 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.16 annualized dividend and a yield of 0.2%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s payout ratio is currently 3.38%.

Hedge Funds Weigh In On GE HealthCare Technologies

Institutional investors and hedge funds have recently modified their holdings of the business. Chicago Partners Investment Group LLC increased its position in shares of GE HealthCare Technologies by 1.9% in the third quarter. Chicago Partners Investment Group LLC now owns 7,246 shares of the company’s stock worth $518,000 after purchasing an additional 133 shares during the period. Ascent Group LLC bought a new position in GE HealthCare Technologies in the 3rd quarter valued at approximately $453,000. Pzena Investment Management LLC acquired a new stake in shares of GE HealthCare Technologies during the 3rd quarter valued at $82,085,000. Rakuten Investment Management Inc. boosted its stake in shares of GE HealthCare Technologies by 9.9% during the third quarter. Rakuten Investment Management Inc. now owns 121,395 shares of the company’s stock valued at $8,068,000 after purchasing an additional 10,897 shares in the last quarter. Finally, Provenance Wealth Advisors LLC grew its holdings in GE HealthCare Technologies by 401.0% during the 3rd quarter. Provenance Wealth Advisors LLC now owns 491 shares of the company’s stock worth $32,000 after acquiring an additional 393 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Strong Q3 results beat expectations. GE HealthCare reported $5.51 billion in revenue, above the $5.35 billion consensus estimate, while EPS of $1.34 exceeded expectations of $1.20. Revenue increased 7.2% year over year, helping drive the post-earnings gap higher. GE HealthCare Technologies Shares Gap Up After Strong Earnings
• Positive Sentiment: Management raised its full-year outlook. The company now expects approximately 4% organic revenue growth, adjusted EPS of $4.95–$5.05, and at least $1.6 billion in free cash flow. Organic growth of 6.2% and margin expansion in the quarter further strengthened the bullish case. GE HealthCare: Broad-Based Growth Makes The Bull Case More Compelling
• Positive Sentiment: Analysts raised valuation targets. RBC increased its target from $80 to $90 and maintained an “outperform” rating. BNP Paribas lifted its target from $96 to $100, while Mizuho raised its target from $85 to $90. BTIG Research also forecast substantial potential appreciation. BNP Paribas Price Target Update
• Neutral Sentiment: JPMorgan raised its price target from $70 to $80 but kept a “neutral” rating, suggesting recognition of the earnings improvement while retaining a cautious stance on valuation. JPMorgan GE HealthCare Rating
• Neutral Sentiment: A value comparison with Haemonetics highlights GEHC’s investment appeal but does not introduce a material new catalyst for the stock. GEHC Versus HAE Value Comparison

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc is a global medical technology company that develops and provides products, services and digital solutions for healthcare providers. Its offerings are designed to support the diagnosis, treatment and monitoring of patients across hospitals, outpatient facilities, imaging centers and other care settings.

The company’s portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, molecular imaging, surgical imaging and X-ray equipment.